Valarie Traynham, a cancer thriver and patient advocate, imparts advice and discusses survivorship after a cancer diagnosis.

Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized ...

Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care ...

After years off medication, I finally enjoyed a grapefruit cocktail — symbolizing freedom from cancer’s constant shadow and ...

Waldenström macroglobulinemia is often slow growing, with a 78% five-year survival rate, but chronic conditions can affect ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

In part 2 of “This Wasn't the Plan,” a young woman recalls her stage 4 blood cancer diagnosis and how chemotherapy revealed ...

Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to ...

Dr. Alexandra Zaleta discusses how most cancer patients face prior authorization delays, despite 95% being approved, ...

Valarie Traynham discusses some of ways her life has changed since being diagnoses with cancer, and what parts of her ...